期刊文献+

偏头痛的发作机制及药物治疗策略 被引量:6

下载PDF
导出
摘要 偏头痛(migranine)是一种常见发作性神经血管疾病.其特征是发作性、多为偏侧的、中重度、博动样头痛,一般持续4—72h,可伴有恶心、呕吐,光、声或活动可加重头痛,安静环境中休息则可缓解头痛。发病率在欧美等国家为10%-15%。WHO将严重偏头痛定为最致残的慢性疾病之一。目前,对偏头痛的发病机制研究已取得一定进展,但对其适当的药物治疗,仍不甚理想。
出处 《中国药师》 CAS 2008年第9期1108-1110,共3页 China Pharmacist
关键词 偏头痛 机制 治疗
  • 相关文献

参考文献20

  • 1偏头痛诊断与防治专家共识组,李焰生.偏头痛诊断与防治专家共识[J].中华内科杂志,2006,45(8):694-696. 被引量:322
  • 2叶小菊,胡兴越.偏头痛发病机制的研究进展[J].国外医学(神经病学.神经外科学分册),2005,32(3):280-283. 被引量:49
  • 3Welch KM, Cutrer FM, Goadsby PJ. Migraine pathogenesis : Neural and vascularmechanisms[J]. Neurology, 2003,60(7,Supp 12) :S9-S14
  • 4Petersen KA, Lassen LH, Birk S, et al. B IBN4096BS antagonizes human alpha2 calcitonin gene related pepfide 2 induced headache and extracerebral artery dilatation[J]. Clin Pharmacol Ther, 2005, 77 (3) :202-213
  • 5Nardone R, Tezzon F. Short latency trigemino -temoeleidomastoid response in patients with migTaine[J]. J Neurol, 2003, 250 (6) : 725-732
  • 6Estevez M, Gardner KL. Update on the genetics of migraine[ J]. Human Genetics, 2004, 114(3) :225-235
  • 7Umberto P ,Massimo DL ,Enrico DB. Prophylactic activity of increas2 ing doses of intravenous histamine in refractory migraine : Retrospective observations of a series of patients with migraine without aura [ J ]. Current Therapeutic Research ,2004,65 ( 1 ) :70-78
  • 8Filica V, Vladicb A, Stefulj J, et al. Monoamine oxidasesA and B gene polymorphisms in migraine patients[J]. J Neurol Sci, 2005, 228(2) : 149-153
  • 9Sarchielli P , Alberti A ,Vaianella L , et al. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks [ J ]. Headache, 2004,44 (10) :961-968
  • 10Estevez M, Gardner KL. Update on the genetics of migraine[ J]. Human Genetics, 2004, 114 (3):225-235

二级参考文献46

  • 1郭述苏,薛广波.中国偏头痛流行病学初步调查[J].中华流行病学杂志,1993,14(2):102-105. 被引量:47
  • 2王忠诚 程学铭 等.中国六城市居民神经系统疾病的流行病学调查[J].中华神经外科杂志,1985,1:2-4.
  • 3中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中华人民共和国卫生部,1995.10-15.
  • 4[1]Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, Cranial neuralgias and facial pain. Cephalalgia, 1988, 8( Suppl 7) : 1.
  • 5[3]Barolin GS. Headache and (concomitant) depression. Psychopathology, 1986, 19: 165 ~ 167.
  • 6[6]Boyer W. F. Potential Indication for the Selective Serotonin Reuptake Inhibitors. Int Clin Psychopharmacology, 1992, 6: 5 ~ 12.
  • 7Classification and diagnostic criteria for headache disorders cranial neuralgias pain[S]. Headache Classification Commiffee of International Headache Society Cephiagia,1998, (supp 17):12.
  • 8谭公平.血栓病与中风防治[M].北京:光明日报出版社,1990.201.
  • 9Aurora SK, Ahmad BK, Welch KMA, et al. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine.Neurology, 1998, 50: 1111-1114.
  • 10Mulleners WM, Chronicle EP, Vredeveld JW, et al. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol, 2002,9:35-40.

共引文献366

同被引文献76

引证文献6

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部